NCT06300879
- Conditions
- Adenocarcinoma of Esophagogastric Junction, Digestive System Diseases, Digestive System Neoplasms, +7 more
- Locations
-
- Huashan Hospital, Fudan University Shanghai, Shanghai Municipality, China
Clinical trial condition
Adenocarcinoma of Esophagogastric Junction
Explore clinical trials studying Adenocarcinoma of Esophagogastric Junction. Study availability and eligibility vary by location and protocol.
8 public trials
4 recruiting studies
Adenocarcinoma of Esophagogastric Junction trial results
NCT05715931
- Conditions
- Adenocarcinoma of Esophagogastric Junction, Adenocarcinoma of the Stomach, HER2-positive Gastric Cancer
- Locations
-
- The First Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China
- The Second Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China
- Huzhou Central Hospital Huzhou, Zhejiang, China
- Lishui Central Hospital Lishui, Zhejiang, China
NCT05872685
- Conditions
- Adenocarcinoma of Esophagogastric Junction, Adenocarcinoma of the Stomach, Proficient Mismatch Repair
- Locations
-
- The First Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China
- The Second Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China
- Lishui Central Hospital Lishui, Zhejiang, China
- Ningbo Medical Center LiHuiLi Hospital Ningbo, Zhejiang, China
NCT05729646
- Conditions
- Adenocarcinoma of Esophagogastric Junction, Adenocarcinoma of the Stomach, Mismatch Repair Deficiency, +1 more
- Locations
-
- The First Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China
- The Second Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China
- Huzhou Central Hospital Huzhou, Zhejiang, China
- Lishui Central Hospital Lishui, Zhejiang, China
Not Yet Recruiting
Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Adenocarcinoma of Gastric/Esophagogastric Junction
NCT07406984
- Conditions
- Adenocarcinoma of Esophagogastric Junction, Adenocarcinoma of Gastric
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
Not Yet Recruiting
Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA
NCT06222944
- Conditions
- Adenocarcinoma of Esophagogastric Junction, Digestive System Diseases, Digestive System Neoplasms, +7 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
Not Yet Recruiting
Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
NCT05970627
- Conditions
- Adenocarcinoma of Esophagogastric Junction, Adenocarcinoma of the Stomach, Epstein-Barr Virus-Associated Gastric Carcinoma
- Locations
-
- The First Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China
- The Second Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China
- Huzhou Central Hospital Huzhou, Zhejiang, China
- Lishui Central Hospital Lishui, Zhejiang, China
Not Yet Recruiting
Neoadjuvant Immunotherapy and Chemoradiotherapy for Locally Advanced Esophagogastric Junction Adenocarcinoma
NCT05505461
- Conditions
- Adenocarcinoma of Esophagogastric Junction, Parkinson Disease 4, Autosomal Dominant Lewy Body
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China